Mendel Partners are the world’s first Biotech Start-Up Partners exclusively dedicated to Advanced Therapies and Rare Diseases. We help Advanced Therapies and Rare Disease Biotech clients across the globe to attract best-in-class investors, boards & leadership teams that make meaningful differences to patients & shareholders alike. Our exclusive commitment to these small but rapidly emerging sectors means our clients gain access to the limited number of business-critical experts that cannot otherwise be found through more traditional search practices - to compensate for the severe lack of volume in our sector’s talent pools, we instead focus on high-quality personalised sourcing & candidate management practices. For our start-up clients currently operating with little or no capital, we have also developed some completely unique fee models that enable them to attract business-critical expertise and funding much earlier than usually achievable, thus optimising their success without the huge reimbursement costs usually associated with doing so.